Scholar Rock Holding sell Biotechhunter
Start price
31.07.20
/
50%
€9.40
Target price
04.11.21
-
Performance (%)
151.06%
End price
15.07.21
€23.60
Summary
This prediction ended on 15.07.21 with a price of €23.60. The price for Scholar Rock Holding massively increased, which is bad news for the SELL prediction by Biotechhunter. Biotechhunter has 50% into this predictionScholar Rock is a clinical-stage biopharmaceutical company that engages in the discovery and development of innovative medicines to treat serious diseases in patients that currently have limited or no treatment options. Their pipeline consists of a number of product candidates that target growth factor signaling pathways within the human body. These products hold potential for the treatment of multiple diseases, including neuromuscular disorders, cancer, and fibrosis. Scholar Rock, which trades under the symbol SRRK, is listed on the NASDAQ stock exchange.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Scholar Rock Holding | 6.977% | 6.977% | 102.941% | - |
| iShares Core DAX® | 1.804% | -0.748% | 13.168% | 16.408% |
| iShares Nasdaq 100 | -0.182% | -3.412% | 39.976% | 43.502% |
| iShares Nikkei 225® | 0.413% | -7.381% | 18.776% | 2.874% |
| iShares S&P 500 | 0.664% | -1.941% | 28.141% | 42.155% |